Cannabinoid CB2 receptor as a new phototherapy target for the inhibition of tumor growth

Molecular Pharmaceutics

Volumn 11, Issue 6, 2014, Pages 1919-1929

  Jia, Ningyang ^a,b   Zhang, Shaojuan ^b,c   Shao, Pin ^b   Bagia, Christina ^d   Janjic, Jelena M ^d   Ding, Ying ^e   Bai, Mingfeng ^b,f,g  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d DUQUESNE UNIVERSITY   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^g University of Pittsburgh   (United States)

Author keywords

cancer; cannabinoid; CB2 receptor; phototherapy; targeted therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CANNABINOID 2 RECEPTOR; IR 700DX MBC 94; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG; INDOLE DERIVATIVE; IR700DX-MBC94; ORGANOSILICON DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; FEMALE; IRRADIATION; LIGHT; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; RECEPTOR BINDING; ANIMAL; CELL DEATH; DRUG EFFECTS; METABOLISM; NEOPLASMS; PROCEDURES; TUMOR CELL LINE;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; INDOLES; MICE; NEOPLASMS; ORGANOSILICON COMPOUNDS; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; RECEPTOR, CANNABINOID, CB2;

EID: 84901811027     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp5001923     Document Type: Article

References (41)

1. Celli, J. P.; Spring, B. Q.; Rizvi, I.; Evans, C. L.; Samkoe, K. S.; Verma, S.; Pogue, B. W.; Hasan, T. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization Chem. Rev. 2010, 110, 2795-2838
2. Stefflova, K.; Li, H.; Chen, J.; Zheng, G. Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent Bioconjugate Chem. 2007, 18 (2) 379-388
3. Agostinis, P.; Berg, K.; Cengel, K. A.; Foster, T. H.; Girotti, A. W.; Gollnick, S. O.; Hahn, S. M.; Hamblin, M. R.; Juzeniene, A.; Kessel, D.; Korbelik, M.; Moan, J.; Mroz, P.; Nowis, D.; Piette, J.; Wilson, B. C.; Golab, J. Photodynamic therapy of cancer: an update CA: Cancer J. Clin. 2011, 61 (4) 250-281
4. Hudson, R.; Boyle, R. W. Strategies for selective delivery of photodynamic sensitisers to biological targets J. Porphyrins Phthalocyanines 2004, 08 (07) 954-975
5. Mitsunaga, M.; Ogawa, M.; Kosaka, N.; Rosenblum, L. T.; Choyke, P. L.; Kobayashi, H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules Nat. Med. 2011, 17 (12) 1685-1691
6. Choi, Y.; McCarthy, J. R.; Weissleder, R.; Tung, C. H. Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy ChemMedChem 2006, 1 (4) 458-463
7. Taratula, O.; Schumann, C.; Naleway, M. A.; Pang, A. J.; Chon, K. J.; Taratula, O. A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy Mol. Pharmaceutics 2013, 10 (10) 3946-3958
8. Master, A.; Malamas, A.; Solanki, R.; Clausen, D. M.; Eiseman, J. L.; Sen Gupta, A. A cell-targeted photodynamic nanomedicine strategy for head and neck cancers Mol. Pharmaceutics 2013, 10 (5) 1988-1997
9. Scotter, E. L.; Abood, M. E.; Glass, M. The endocannabinoid system as a target for the treatment of neurodegenerative disease Br. J. Pharmacol. 2010, 160 (3) 480-498
10. Blazquez, C.; Carracedo, A.; Barrado, L.; Real, P. J.; Fernandez-Luna, J. L.; Velasco, G.; Malumbres, M.; Guzman, M. Cannabinoid receptors as novel targets for the treatment of melanoma FASEB J. 2006, 20 (14) 2633-2635
11. Qamri, Z.; Preet, A.; Nasser, M. W.; Bass, C. E.; Leone, G.; Barsky, S. H.; Ganju, R. K. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer Mol. Cancer Ther. 2009, 8 (11) 3117-3129
12. Sarfaraz, S.; Afaq, F.; Adhami, V. M.; Malik, A.; Mukhtar, H. Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest J. Biol. Chem. 2006, 281 (51) 39480-39491
13. Xu, X.; Liu, Y.; Huang, S.; Liu, G.; Xie, C.; Zhou, J.; Fan, W.; Li, Q.; Wang, Q.; Zhong, D.; Miao, X. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma Cancer Genet. Cytogenet. 2006, 171 (1) 31-38
14. Velasco, G.; Sanchez, C.; Guzman, M. Towards the use of cannabinoids as antitumour agents Nat. Rev. Cancer 2012, 12 (6) 436-444
15. Zhang, S.; Jia, N.; Shao, P.; Tong, Q.; Xie, X.-Q.; Bai, M. Target-Selective Phototherapy Using a Ligand-Based Photosensitizer for Type 2 Cannabinoid Receptor Chem. Biol. 2014, 21, 338-344
16. Cudaback, E.; Marrs, W.; Moeller, T.; Stella, N. The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas PLoS One 2010, 5 (1) e8702
17. Zhang, S.; Shao, P.; Bai, M. In vivo type 2 cannabinoid receptor-targeted tumor optical imaging using a near infrared fluorescent probe Bioconjugate Chem. 2013, 24 (11) 1907-1916
18. Tomayko, M. M.; Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice Cancer Chemother. Pharmacol. 1989, 24 (3) 148-154
19. Dolmans, D. E.; Fukumura, D.; Jain, R. K. Photodynamic therapy for cancer Nat. Rev. Cancer 2003, 3 (5) 380-387
20. Sagone, A. L., Jr.; Husney, R. M.; Wewers, M. D.; Herzyk, D. J.; Davis, W. B. Effect of dimethylthiourea on the neutrophil myeloperoxidase pathway J. Appl. Physiol. 1989, 67 (3) 1056-1062
21. Yogo, T.; Urano, Y.; Ishitsuka, Y.; Maniwa, F.; Nagano, T. Highly efficient and photostable photosensitizer based on BODIPY chromophore J. Am. Chem. Soc. 2005, 127 (35) 12162-12163
22. Urruticoechea, A.; Alemany, R.; Balart, J.; Villanueva, A.; Vinals, F.; Capella, G. Recent advances in cancer therapy: an overview Curr. Pharm. Des. 2010, 16 (1) 3-10
23. Hudziak, R. M.; Lewis, G. D.; Winget, M.; Fendly, B. M.; Shepard, H. M.; Ullrich, A. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor Mol. Cell. Biol. 1989, 9 (3) 1165-1172
24. Wu, H. C.; Chang, D. K.; Huang, C. T. Targeted therapy of cancer J. Cancer Mol. 2006, 2 (2) 57-66
25. Munro, S.; Thomas, K. L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids Nature 1993, 365 (6441) 61-65
26. Sexton, M.; Woodruff, G.; Horne, E. A.; Lin, Y. H.; Muccioli, G. G.; Bai, M.; Stern, E.; Bornhop, D. J.; Stella, N. NIR-mbc94, a fluorescent ligand that binds to endogenous CB(2) receptors and is amenable to high-throughput screening Chem. Biol. 2011, 18 (5) 563-568
27. Caffarel, M. M.; Andradas, C.; Perez-Gomez, E.; Guzman, M.; Sanchez, C. Cannabinoids: A new hope for breast cancer therapy? Cancer Treat Rev. 2012, 38 (7) 911-918
28. Olea-Herrero, N.; Vara, D.; Malagarie-Cazenave, S.; Diaz-Laviada, I. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2 Br. J. Cancer 2009, 101 (6) 940-950
29. Sarfaraz, S.; Afaq, F.; Adhami, V. M.; Mukhtar, H. Cannabinoid receptor as a novel target for the treatment of prostate cancer Cancer Res. 2005, 65 (5) 1635-1641
30. Sanchez, C.; de Ceballos, M. L.; del Pulgar, T. G.; Rueda, D.; Corbacho, C.; Velasco, G.; Galve-Roperh, I.; Huffman, J. W.; Cajal, S. R. Y.; Guzman, M. Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor Cancer Res. 2001, 61 (15) 5784-5789
31. Cianchi, F.; Papucci, L.; Schiavone, N.; Lulli, M.; Magnelli, L.; Vinci, M. C.; Messerini, L.; Manera, C.; Ronconi, E.; Romagnani, P.; Donnini, M.; Perigli, G.; Trallori, G.; Tanganelli, E.; Capaccioli, S.; Masini, E. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells Clin. Cancer Res. 2008, 14 (23) 7691-7700
32. Preet, A.; Qamri, Z.; Nasser, M. W.; Prasad, A.; Shilo, K.; Zou, X. H.; Groopman, J. E.; Ganju, R. K. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis Cancer Prev Res. 2011, 4 (1) 65-75
33. Shi, Y.; Zou, M.; Baitei, E. Y.; Alzahrani, A. S.; Parhar, R. S.; Al-Makhalafi, Z.; Al-Mohanna, F. A. Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma Cancer Gene Ther. 2008, 15 (2) 101-107
34. McKallip, R. J.; Lombard, C.; Fisher, M.; Martin, B. R.; Ryu, S. H.; Grant, S.; Nagarkatti, P. S.; Nagarkatti, M. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease Blood 2002, 100 (2) 627-634
35. Carracedo, A.; Gironella, M.; Lorente, M.; Garcia, S.; Guzman, M.; Velasco, G.; Iovanna, J. L. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes Cancer Res. 2006, 66 (13) 6748-6755
36. Vara, D.; Salazar, M.; Olea-Herrero, N.; Guzman, M.; Velasco, G.; Diaz-Laviada, I. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy Cell Death Differ. 2011, 18 (7) 1099-1111
37. Mitsunaga, M.; Ogawa, M.; Kosaka, N.; Rosenblum, L. T.; Choyke, P. L.; Kobayashi, H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules Nat. Med. 2011, 17 (12) 1685-1691
38. Mroz, P.; Yaroslavsky, A.; Kharkwal, G. B.; Hamblin, M. R. Cell death pathways in photodynamic therapy of cancer Cancers 2011, 3 (2) 2516-2539
39. Danial, N. N.; Korsmeyer, S. J. Cell death: critical control points Cell 2004, 116 (2) 205-219
40. Mitsunaga, M.; Nakajima, T.; Sano, K.; Kramer-Marek, G.; Choyke, P. L.; Kobayashi, H. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy BMC Cancer 2012, 12, 345
41. Sexton, M.; Woodruff, G.; Horne, E. A.; Lin, Y. H.; Muccioli, G. G.; Bai, M.; Stern, E.; Bornhop, D. J.; Stella, N. NIR-mbc94, a fluorescent ligand that binds to endogenous CB(2) receptors and is amenable to high-throughput screening Chem. Biol. 2011, 18 (5) 563-568